Russell Frank Company’s Lifecore Biomedical LFCR Stock Holding History

Russell Frank Company’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.52M	Buy	430,848 +16,797	+4%	+$184K	0.01%	1399
2015 Q4	$5.04M	Sell	414,051 -7,246	-2%	-$89K	0.01%	1278
2015 Q3	$4.92M	Buy	421,297 +68,232	+19%	+$904K	0.01%	1278
2015 Q2	$5.09M	Buy	353,065 +201,809	+133%	+$2.91M	0.01%	1404
2015 Q1	$2.11M	Buy	151,256 +9,043	+6%	+$125K	﹤0.01%	1745
2014 Q4	$2.01M	Sell	142,213 -3,800	-3%	-$49.1K	﹤0.01%	1792
2014 Q3	$1.79M	Sell	146,013 -1,700	-1%	-$21.2K	﹤0.01%	1794
2014 Q2	$1.8M	Buy	147,713 +8,745	+6%	+$103K	﹤0.01%	1812
2014 Q1	$1.67M	Buy	138,968 +58,500	+73%	+$642K	﹤0.01%	1854
2013 Q4	$866K	Buy	80,468 +25,164	+46%	+$300K	﹤0.01%	2135
2013 Q3	$674K	Sell	55,304 -10,125	-15%	-$141K	﹤0.01%	2373
2013 Q2	$864K	Buy	+65,429	New	+$905K	﹤0.01%	2124

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Russell Frank Company's LFCR Position: Q1 2016 in Review

Russell Frank Company increased its Lifecore Biomedical (LFCR) stake by 4.1% in Q1 2016, buying an estimated $184K and bringing the position to 430,848 shares worth $4.52M. The position accounts for 0.01% of the portfolio, ranked #1399.

Russell Frank Company first reported a position in LFCR in Q2 2013 and has held it in 12 quarters since. The position peaked at $5.09M in Q2 2015. 96 funds tracked by Wall St. Rank hold LFCR as of Q1 2016.

Russell Frank Company held 430,848 shares of Lifecore Biomedical worth $4.52M as of Q1 2016.
Russell Frank Company bought 16,797 Lifecore Biomedical shares in Q1 2016, an estimated $184K.
Lifecore Biomedical made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1399 holding.
Russell Frank Company first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Lifecore Biomedical position peaked at $5.09M in Q2 2015.
96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.